Literature DB >> 11462028

Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.

J T Thomas1, S T Oh, S S Terhune, L A Laimins.   

Abstract

Infections by low-risk papillomavirus types, such as human papillomavirus (HPV) type 6 (HPV-6) and HPV-11, induce benign genital warts that rarely progress to malignancy. In contrast, lesions induced by high-risk HPV types have the potential to progress to cancer. Considerable information is available concerning the pathogenesis of high-risk HPV types, but little is known about the life cycle of low-risk HPV types. Although functionally distinct, both high- and low-risk virus types infect keratinocytes and induce virion production upon differentiation. This information suggests that they may share common mechanisms for regulating their productive life cycles. Using tissue culture methods developed to study high-risk HPV types, we examined the ability of HPV-11 to be stably maintained as episomes following transfection of normal human keratinocytes with cloned viral DNA. HPV-11 genomes were found to be maintained in keratinocytes for extended passages in cultures in 14 independent experiments involving transfection of cloned HPV-11 DNA. Interestingly, the HPV-11-positive cells exhibited an extended life span that averaged approximately twofold longer than that of control neomycin-transfected cells. In organotypic cultures, HPV-11-positive cells exhibited altered differentiation patterns, but the extent of disruption was less severe than that seen with high-risk HPV types. In addition, the amplification of HPV-11 DNA, as well as the induction of several viral messages, was observed following differentiation of transfected cells in semisolid media. To determine whether global changes in cellular gene expression induced by HPV-11 were similar to those observed with high-risk HPV-31 (Y. E. Chang and L. A. Laimins, J. Virol. 74:4174-4182, 2000), microarray analysis of 7,075 expressed sequences was performed. A spectrum of cellular genes different from that previously reported for HPV-31 was found to be activated or repressed by HPV-11. The expression of only a small set of genes was similarly altered by both high- and low-risk HPV types. This result suggests that different classes of HPVs have distinct effects on global cellular transcription patterns during infection. The methods described allow for a genetic analysis of HPV-11 in the context of its differentiation-dependent life cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462028      PMCID: PMC114991          DOI: 10.1128/JVI.75.16.7564-7571.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle.

Authors:  S S Terhune; C Milcarek; L A Laimins
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms.

Authors:  D Smotkin; H Prokoph; F O Wettstein
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.

Authors:  J R Gage; C Meyers; F O Wettstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.

Authors:  Y E Chang; L A Laimins
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  A human papilloma virus type 11 transcript encoding an E1--E4 protein.

Authors:  M Nasseri; R Hirochika; T R Broker; L T Chow
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

8.  The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Replication of plasmid-derived human papillomavirus type 11 DNA in cultured keratinocytes.

Authors:  S Mungal; B M Steinberg; L B Taichman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.

Authors:  M G Frattini; H B Lim; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  26 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

4.  Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Nicholas J Genovese; Francisco Noya; Wei-Ming Chien; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 5.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

6.  HPV episome levels are potently decreased by pyrrole-imidazole polyamides.

Authors:  Terri G Edwards; Kevin J Koeller; Urszula Slomczynska; Kam Fok; Michael Helmus; James K Bashkin; Chris Fisher
Journal:  Antiviral Res       Date:  2011-06-02       Impact factor: 5.970

7.  Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling.

Authors:  Nicole Baumgarth; Richard Szubin; Greg M Dolganov; Mitchell R Watnik; Deborah Greenspan; Maria Da Costa; Joel M Palefsky; Richard Jordan; Mario Roederer; John S Greenspan
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Gene chip technology used in the detection of HPV infection in esophageal cancer of Kazakh Chinese in Xinjiang Province.

Authors:  Wei-Gang Chen; Chun-Mei Yang; Li-Hong Xu; Ning Zhang; Xiao-Yan Liu; Yun-Gui Ma; Xiao-Ling Huo; Yu-Sheng Han; De-An Tian; Yong Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

9.  Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Authors:  Julie M Kneller; Thomas Ehlen; Jasenka P Matisic; Dianne Miller; Dirk Van Niekerk; Wan L Lam; Marco Marra; Rebecca Richards-Kortum; Michelle Follen; Calum Macaulay; Steven J M Jones
Journal:  Biomark Insights       Date:  2007-12-11

10.  In vivo and in vitro intragenomic rearrangement of TT viruses.

Authors:  Ludmila Leppik; Karin Gunst; Matti Lehtinen; Joakim Dillner; Karin Streker; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.